CK-2127107 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Reldesemtiv is a potential treatment of spinal muscular atrophy (SMA); A novel fast skeletal troponin activator on skeletal muscle function and exercise performance in rats.

CK-2127107 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

CK-2127107 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Jinan Carbotang Biotech Co.,Ltd.	+8615866703830	figo.gao@foxmail.com	China	8497	58
TargetMol Chemicals Inc.	+17819995354	marketing@targetmol.com	United States	32281	58
HANGZHOU CLAP TECHNOLOGY CO.,LTD	86-571-88216897,88216896 13588875226	sales@hzclap.com	CHINA	6312	58
Wuhan Topule Biopharmaceutical Co., Ltd	+8618327326525	masar@topule.com	China	8467	58
Zibo Hangyu Biotechnology Development Co., Ltd	+86-0533-2185556 +8615965530500	nickzhang@hangyubiotech.com	China	10968	58
Suzhou ARTK Medchem Co., Ltd.	+86-512-68323658 +86-18168183658	sales1@artkmedchem.com	China	39004	58
Elucigen bio	13501719342	wayne.zheng@elucigenbio.com	China	5000	58
ShangHai Caerulum Pharma Discovery Co., Ltd.	18149758185 18149758185	sales-cpd@caerulumpharma.com	China	3467	58
Shanghai Shanyuan pharmaceutical technology co., LTD	021-31761238 13167072949	3146446224@qq.com	China	1371	55
Guangzhou Belka Biological Technology Co., Ltd.	+86-18665676617		China	957	58

---

• CK-2127107
• Reldesemtiv
• 1H-Pyrrole-3-carboxamide, 1-[2-[[[trans-3-fluoro-1-(3-fluoro-2-pyridinyl)cyclobutyl]methyl]amino]-5-pyrimidinyl]-
• Reldesemtiv, 10 mM in DMSO
• 1345410-31-2